BOOTHBAY FUND MANAGEMENT, LLC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 91 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$56,100
-25.5%
30,0000.0%0.00%
-50.0%
Q2 2023$75,300
-95.7%
30,000
-97.0%
0.00%
-94.4%
Q1 2023$1,742,991
+85.4%
995,995
+350.3%
0.04%
+63.6%
Q4 2022$940,121
+1046.5%
221,205
+171.2%
0.02%
+1000.0%
Q2 2022$82,000
-78.4%
81,559
-47.4%
0.00%
-77.8%
Q1 2022$380,000154,9500.01%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders